Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
2025;:10.1038/s41584-025-01302-0
An estimated 828 million adults were affected globally in 2022, up by 630 million since 1990, according to research from the NCD Risk Factor Collaboration (NCD-RisC) 1
Furthermore, impaired cerebral metabolism appears to be an early-stage biomarker for ADRD, as several studies have shown reduced glucose metabolism in the hippocampus and posterior cingulate prior to observation of overt clinical symptoms (i.e., cognitive impairment) (Kumar et al., 2022
The functional medicine approach how to pair GLP-1 therapy with tailored nutrition, movement, and stress management plans
US$ 20.85
US$ 27.63
.webp)
US$ 22.85
US$ 28.91
US$ 21.40
